Concepedia

Recombinant Soluble Form of PSGL-1 Accelerates Thrombolysis and Prevents Reocclusion in a Porcine Model

Anjali Kumar, Mario P. Villani, Umesh Patel, James C. Keith, Robert G. Schaub

Circulation · 1999 · 115 citations · 41 references

DOI

Abstract

Inhibition of leukocyte accumulation at the site of thrombosis with rPSGL-Ig may represent a safe therapeutic intervention that could be important in accelerating thrombolysis, achieving optimal reperfusion, and reducing incidence of acute reocclusion.

References

41

The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes

New England Journal of Medicine · 1992 · 3.7K citations

The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes

Franklin H. Epstein, Valentı́n Fuster, Lina Badimón et al. · New England Journal of Medicine · 1992 · 2.7K citations

, , +23

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.2K citations · Full text

, , +15

The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts)

Valentı́n Fuster · New England Journal of Medicine · 1992 · 2K citations

, , +10

The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction

The GUSTO Angiographic Investigators · New England Journal of Medicine · 1993 · 1.9K citations · Full text